Serum bilirubin is associated with lung function in a Swiss general population sample

European Respiratory Journal

Volumn 43, Issue 5, 2014, Pages 1278-1288

  Curjuric, Ivan ^a,b   Imboden, Medea ^a,b   Adam, Martin ^a,b   Bettschart, Robert W ^c   Gerbase, Margaret W ^d   Künzli, Nino ^a,b   Rochat, Thierry ^d   Rohrer, Lucia ^e   Rothe, Thomas B ^f   Schwartz, Joel ^g   Stolz, Daiana ^h   Tschopp, Jean Marie ⁱ   Von Eckardstein, Arnold ^e   Kronenberg, Florian ^j   Probst Hensch, Nicole M ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c KLINIK HIRSLANDEN   (Switzerland)

^d UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f Dept of Internal Medicine and Pneumology Zürcher Höhenklinik Davos ^*  (Switzerland)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ Centre Valaisan de Pneumologie   (Switzerland)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; BIOLOGICAL MARKER;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG PROTECTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTECTION; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPIROMETRY; SUSCEPTIBLE POPULATION; SWISS; UGT1A1 GENE; ADOLESCENT; ADVERSE EFFECTS; BLOOD; BREATHING DISORDER; GENETICS; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; SWITZERLAND; VITAL CAPACITY; YOUNG ADULT;

ADOLESCENT; ADULT; BILIRUBIN; BIOMARKERS; BODY MASS INDEX; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; RESPIRATION DISORDERS; RESPIRATORY FUNCTION TESTS; SMOKING; SPIROMETRY; SWITZERLAND; VITAL CAPACITY; YOUNG ADULT;

EID: 84899883712     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00055813     Document Type: Article

References (30)

1. Kronenberg F. Association of bilirubin with cardiovascular outcomes: more hype than substance? Circ Cardiovasc Genet 2010; 3: 308-310.
2. Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008; 198: 1-11.
3. Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010; 56: 1535-1543.
4. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046.
5. Horsfall LJ, Rait G, Walters K, et al. Serum bilirubin and risk of respiratory disease and death. JAMA 2011; 305: 691-697.
6. Temme EH, Zhang J, Schouten EG, et al. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001; 12: 887-894.
7. Breimer LH, Wannamethee G, Ebrahim S, et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995; 41: 1504-1508.
8. Rodrigues C, Costa E, Vieira E, et al. Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index. Am J Med Sci 2012; 343: 114-118.
9. Jo J, Kimm H, Yun JE, et al. Cigarette smoking and serum bilirubin subtypes in healthy Korean men: the Korea Medical Institute study. J Prev Med Public Health 2012; 45: 105-112.
10. Johnson AD, Kavousi M, Smith AV, et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009; 18: 2700-2710.
11. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDPglucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333: 1171-1175.
12. Lin JP, O'Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006; 114: 1476-1481.
13. Lin R, Wang Y, Fu W, et al. Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population. Pharmacogenet Genomics 2009; 19: 310-318.
14. Bosma PJ, van der Meer IM, Bakker CT, et al. UGT1A1*28 allele and coronary heart disease: the Rotterdam Study. Clin Chem 2003; 49: 1180-1181.
15. Ekblom K, Marklund SL, Jansson JH, et al. Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective, nested case-referent setting. Circ Cardiovasc Genet 2010; 3: 340-347.
16. Gajdos V, Petit FM, Perret C, et al. Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: The ECTIM Study. Clin Chem 2006; 52: 2313-2314.
17. Lingenhel A, Kollerits B, Schwaiger JP, et al. Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease. Exp Gerontol 2008; 43: 1102-1107.
18. Rantner B, Kollerits B, Anderwald-Stadler M, et al. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin Chem 2008; 54: 851-857.
19. Stender S, Frikke-Schmidt R, Nordestgaard BG, et al. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis. J Intern Med 2013; 273: 59-68.
20. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, et al. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants. Soz Praventivmed 2005; 50: 245-263.
21. American Thoracic Society. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1285-1298.
22. Wahlefeld AWHG, Bernt E. Modification of the Malloy-Evelyn method for a simple, reliable determination of total bilirubin in serum. Scand J Clin Lab Invest 1972; 29: Suppl. 126, abstract 11.2.
23. Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. New Engl J Med 2010; 363: 1211-1221.
24. Imboden M, Bouzigon E, Curjuric I, et al. Genome-wide association study of lung function decline in adults with and without asthma. J Allergy Clin Immunol 2012; 129: 1218-1228.
25. Bochud M, Rousson V. Usefulness of Mendelian randomization in observational epidemiology. Int J Environ Res Public Health 2010; 7: 711-728.
26. Hamid Q. Pathogenesis of small airways in asthma. Respiration 2012; 84: 4-11.
27. Burgel PR, Bourdin A, Chanez P, et al. Update on the roles of distal airways in COPD. Eur Respir Rev 2011; 20: 7-22.
28. Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999; 274: 10852-10862.
29. McCarty MF. "Iatrogenic Gilbert syndrome" - a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 2007; 69: 974-994.
30. Ryter SW. Bile pigments in pulmonary and vascular disease. Front Pharmacol 2012; 3: 39.